| Withdrawn | A Phase II Study of H56:IC31 in Healthy Adolescents Tuberculosis Infection | Phase 2 | 2018-06-01 |
| Completed | Biological Samples Obtained by Leukapheresis Induced by Two BCG Vaccinations in BCG-naïve Healthy Adults in th Tuberculosis | EARLY_Phase 1 | 2017-08-08 |
| Completed | Safety and Immunogenicity Study of BCG, H4:IC31, and H56:IC31 Revaccination in Healthy Adolescents Tuberculosis | Phase 1 | 2015-05-01 |
| Completed | Leukapheresis Sampling for Immune Responses After BCG Vaccination in BCG-naïve Healthy Adults in the US Tuberculosis | EARLY_Phase 1 | 2015-05-01 |
| Completed | A Phase I Study of Safety & Immunogenicity of AERAS-456 in HIV-Neg. Adults Treated for Drug-susceptible Pulmon Tuberculosis | Phase 1 | 2014-11-21 |
| Completed | Substudy of Protocol TB-018 (NCT01755598): Collection and Storage of Biological Samples for Evaluation of Corr Tuberculosis | — | 2014-08-01 |
| Completed | Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy Ado Tuberculosis | Phase 2 | 2014-02-01 |
| Completed | A Phase I/IIa AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456) Latent Tuberculosis Bacteriology and Histology Unknown, Latent Tuberculosis | Phase 1 / Phase 2 | 2013-08-01 |
| Completed | Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed Infants Tuberculosis | Phase 1 / Phase 2 | 2013-07-01 |
| Completed | Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis Latent Tuberculosis, Latent Tuberculosis Bacteriology and Histology Unknown | Phase 1 | 2011-11-01 |
| Completed | Efficacy Against TB Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485) Tuberculosis, HIV Infections | Phase 2 | 2011-07-01 |
| Completed | A Study to Evaluate Safety and Immunogenicity of AERAS-402 Tuberculosis | Phase 1 | 2011-02-01 |
| Completed | A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults Tuberculosis | Phase 1 | 2011-01-01 |
| Completed | Study of AERAS 422 in Healthy Adults Tuberculosis | Phase 1 | 2010-12-01 |
| Completed | Study of AERAS-402 in Healthy Infants Tuberculosis | Phase 1 / Phase 2 | 2010-09-01 |
| Completed | Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults Tuberculosis, HIV Infections | Phase 2 | 2009-12-01 |
| Completed | A Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosti Tuberculosis | Phase 1 | 2009-10-01 |
| Completed | A Study of MVA85A in Healthy Infants Tuberculosis | Phase 2 | 2009-07-01 |
| Completed | A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 (C-011-404) Tuberculosis | Phase 1 | 2008-12-01 |
| Completed | A Study to Evaluate the Safety of AERAS-402 in Adults Recently Treated for Pulmonary TB Tuberculosis | Phase 2 | 2008-10-01 |
| Completed | A Study to Evaluate Safety and Immunogenicity of AERAS-402 Administered in HIV-negative, BCG-vaccinated, QFT ( Tuberculosis | Phase 1 | 2008-09-01 |
| Completed | A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 Administered in Adults Tuberculosis | Phase 1 | 2008-05-01 |
| Completed | A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Tuberculosis | Phase 1 | 2007-11-01 |